SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-025605
Filing Date
2019-05-13
Accepted
2019-05-13 16:01:50
Documents
1
Period of Report
2019-05-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv521407_4.html 4  
1 OWNERSHIP DOCUMENT tv521407_4.xml 4 3524
  Complete submission text file 0001144204-19-025605.txt   5191
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TAPIMMUNE INC. 1551 EASTLAKE AVE. SEATTLE WA 98102
Business Address
Laskow-Pooley David (Reporting) CIK: 0001638533 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 19818336